Best-performing investors to target as a founder: not just the famous names
- 01Theme 1: VC Returns Are Radically Concentrated
- 02Theme 2: AI Is Already Reshaping Who the Best Investors Are
- 03Theme 3: Capital Efficiency and Concentration Beat Volume and Logo Count
- 04Theme 4: Firm Brand and Individual Partner Quality Are Largely Decoupled
- 05Theme 5: Specialist and Sector-Focused Firms Are Systematically Underrepresented in Mainstream Rankings
1. Key Themes
Theme 1: VC Returns Are Radically Concentrated — and Brand Is a Poor Proxy for Performance
The core premise of the article is that the famous names in VC are not reliably the best-performing ones, and that the gap between top and average is staggering.
"By my estimates, about 5% of venture capitalists have generated roughly 90% of the industry's profits. If you are choosing whom to take money from, the question that matters most is whether your investor sits in that 5%. Fame is an imperfect proxy for it."
The power law applies not just to deals, but to firms themselves:
"By rank 10 the score has dropped to roughly 3,000, less than a third of Sequoia's. By rank 100 it is 245. The top firm scores about 41 times the hundredth."
Theme 2: AI Is Already Reshaping Who the Best Investors Are — In Real Time
The ranking's time-decay mechanism means AI investments are immediately rewarded, and firms that made early concentrated AI bets have rapidly risen in the rankings.
"For 23 of the 100 firms, the single highest-scoring investment is a frontier-AI or AI-infrastructure company. That is nearly a quarter of the list, anchored to a wave of companies most of which did not exist, or were tiny, five years ago."
"Firms that placed early, concentrated bets on the leading AI companies, such as Thrive on OpenAI, Menlo on Anthropic and Lightspeed on Mistral, are rewarded immediately rather than years after the fact."
Theme 3: Capital Efficiency and Concentration Beat Volume and Logo Count
The methodology explicitly penalizes check-spraying strategies and rewards concentrated, board-level involvement.
"Turning $10 million into $2 billion is a different achievement from turning $1 billion into the same $2 billion. Subtracting the cost of every investment rewards capital efficiency and penalizes spraying large checks to manufacture a few headline wins. In our data, roughly three-quarters of investments returned negative net profits."
The unicorn count disconnect makes this vivid:
"SV Angel has backed roughly 139 unicorns yet ranks 31st. Insight Partners has invested in about 124 and ranks 28th... Meanwhile DST Global, with 62 unicorns, ranks 4th, and Thrive is 8th with 47."
Theme 4: Firm Brand and Individual Partner Quality Are Largely Decoupled
One of the most actionable structural insights: the firm name on your term sheet is not predictive of who will actually help you.
"One of the most striking facts in our data is that fully half of our top 100 firms have no partner in our individual top 100. Firm strength and individual strength are far from the same thing, which is precisely why our methodology splits credit between them. The brand does not sit on your board; a person does."
Credit-splitting methodology further confirms this:
"Most return variation traces to individuals rather than institutions... We split it, giving a quarter to the firm where the investment was made and three-quarters to the firm where the partner works now."
Theme 5: Specialist and Sector-Focused Firms Are Systematically Underrepresented in Mainstream Rankings
The article identifies clusters of life-science and crypto-native firms that rank highly but would never appear on generalist media lists.
"A cluster of life-sciences firms earns a place on therapeutics rather than software: OrbiMed (27), Atlas Venture (38), ARCH (49), Versant (61) and Sofinnova (75), all ranking on concentrated, capital-efficient bets. Crypto-native firms such as Paradigm (34), Pantera (76), Multicoin (84) and Polychain (94) rank on a different opportunity set again. The methodology does not privilege any sector; it measures value created, net of cost and decay, wherever it occurs."
"If you are building in a specific space, the best-performing investor for you may be a specialist who will never appear near the top of a generalist media list."
2. Contrarian Perspectives
Contrarian 1: The Forbes Midas List Is Largely Unreliable as a Performance Ranking
The article makes a pointed, data-backed case that the industry's default investor ranking is not reproducible and has low correlation with actual performance data.
"When we tried to reverse-engineer it from its own disclosed methodology, even our best-fitting replication left 49 of its own top 100 absent from the actual list. Among investors who appear on both our ranking and Midas, the correlation is only about 0.27."
This is a striking indictment: a correlation of 0.27 is barely better than noise, meaning founders who use the Midas List as a guide to investor quality are operating on a significantly flawed map.
Contrarian 2: Unicorn Count Is Meaningless — or Worse, Misleading — as a Quality Signal
The conventional signal most founders use to evaluate VCs (portfolio unicorn count) is shown to inversely correlate with quality in several cases.
"How can a firm with a fraction of the unicorn count rank far higher? Because the methodology rewards value actually captured rather than the number of top deals... Expressed as points per unicorn, the spread runs from around six for the highest-volume names to more than eighty for the most concentrated."
A firm with 139 unicorns (SV Angel, rank 31) trails a firm with 47 (Thrive, rank 8) — because small, diluted checks into crowded cap tables create the appearance of success without capturing the economics.
Contrarian 3: Private Unicorn Valuations Are Systematically Overstated by ~50%, Distorting Almost Every VC Comparison
This is a foundational point that undermines most public narratives about VC performance.
"Two companies can both be described as worth $100 billion when one figure is a public market capitalization and the other a private post-money valuation. These are not the same number, because the preferred stock VCs buy carries downside protections that common stock lacks. My work with Will Gornall put the average overstatement for unicorns near 50%."
This means roughly half of the "unicorn value" reported in press coverage is an accounting artifact, not real economic value — a fact that should change how founders, LPs, and journalists interpret VC performance claims.
3. Companies Identified
| Company | Description | Why Mentioned | Quotes |
|---|---|---|---|
| Sequoia Capital | Flagship global VC firm | #1 ranked firm in the 2026 Strebulaev-Jackson ranking | "Sequoia tops the ranking with 10,158 points." |
| Andreessen Horowitz (a16z) | Major Silicon Valley VC | #2 ranked firm | "Andreessen Horowitz is second with 8,292." |
| Accel | Global early-stage VC | #3 ranked firm | Ranked #3 with 4,576 points |
| DST Global | Crossover/late-stage investor | #4 ranked; high score despite only 62 unicorns | "DST Global, with 62 unicorns, ranks 4th" |
| Tiger Global | Hedge fund/crossover investor | #5 ranked; cited as example of low-involvement model | "Crossover and hedge-fund-style firms such as Tiger Global (5)... tend to take large minority stakes with few or no board seats." |
| Thrive Capital | Growth-stage VC | #8 ranked; top deal is OpenAI | "Thrive is 8th with 47 [unicorns]"; "Thrive on OpenAI" |
| Parkway Venture Capital | Early-stage VC founded 2019 | Surprise top-20 entrant; top deal is Figure AI | "Parkway Venture Capital, founded in 2019, sits at 19 on the strength of Figure AI." |
| Notable | VC firm | #20 ranked; cited as underrecognized name | "Notable ranks 20th. Neither is a household name, and both outrank firms whose brands are far better known." |
| Benchmark | Early-stage VC | Cited as deeply involved, board-heavy model | "Sequoia and Benchmark run deeply involved, board-heavy models." |
| Sutter Hill Ventures | Early-stage VC | #26; cited for unique incubation model | "Sutter Hill (26) has effectively incubated companies from scratch." |
| SV Angel | Seed-stage investor | 139 unicorns but only #31 — used to debunk unicorn-count metric | "SV Angel has backed roughly 139 unicorns yet ranks 31st." |
| Paradigm | Crypto-native VC | #34; example of sector-specialist performing well | "Crypto-native firms such as Paradigm (34)..." |
| OrbiMed | Life sciences VC | #27; example of sector-specialist ranking highly | "OrbiMed (27)..." |
| Menlo Ventures | VC firm | Cited for early Anthropic bet driving ranking climb | "Menlo on Anthropic" |
| Lightspeed Venture Partners | Global VC | Cited for early Mistral bet | "Lightspeed on Mistral" |
| Insight Partners | Growth-stage VC | 124 unicorns but only #28 | "Insight Partners has invested in about 124 and ranks 28th." |
| Felicis Ventures | Multi-stage VC | 58 unicorns but #74 | "Felicis has some 58 unicorns to its name and sits at 74th." |
| Bessemer Venture Partners | Multi-stage VC | Oldest firm in top 100; VC roots to 1970s | "The oldest firm in the top 100, Bessemer, traces its venture capital roots to the 1970s." |
| Inflection Ventures | Early-stage VC | Youngest firm in top 100; founded 2022 | "The youngest, Inflection Ventures, was founded in 2022." |
| OpenAI | Frontier AI company | Named by 4 firms as their top deal | "OpenAI is named by four firms" |
| Anthropic | AI safety/frontier AI company | Named by 2 firms as their top deal | "Anthropic... by two each" |
| Figure AI | Robotics/AI company | Top deal for Parkway Venture Capital | "Parkway Venture Capital, founded in 2019, sits at 19 on the strength of Figure AI." |
| xAI | Frontier AI (Elon Musk) | Named by 3 firms as their top deal | "xAI by three" |
| Perplexity | AI search company | Named by 2 firms as their top deal | "Perplexity by two each" |
| Mistral AI | European frontier AI company | Top deal linked to Lightspeed | "Lightspeed on Mistral" |
| Dragoneer Investment Group | Crossover/growth investor | #23; cited as low-involvement model example | "Dragoneer (23)... tend to take large minority stakes with few or no board seats." |
| Altimeter Capital | Crossover investor | #24; low-involvement model | "Altimeter (24)" |
| Coatue Management | Hedge fund/crossover | #29; low-involvement model | "Coatue (29)" |
| Greenoaks Capital | Growth/crossover investor | #44; low-involvement model | "Greenoaks (44)" |
| Atlas Venture | Life sciences VC | #38 | "Atlas Venture (38)" |
| ARCH Venture Partners | Life sciences VC | #49 | "ARCH (49)" |
| Versant Ventures | Life sciences VC | #61 | "Versant (61)" |
| Sofinnova Partners | Life sciences VC | #75 | "Sofinnova (75)" |
| Pantera Capital | Crypto-native VC | #76 | "Pantera (76)" |
| Multicoin Capital | Crypto-native VC | #84 | "Multicoin (84)" |
| Polychain Capital | Crypto-native VC | #94 | "Polychain (94)" |
4. People Identified
| Person | Description | Why Mentioned | Quotes |
|---|---|---|---|
| Ilya Strebulaev | Stanford GSB Professor of Finance; leads Stanford's Venture Capital Initiative; co-author of The Venture Mindset | Author of the ranking and article; primary source of methodology | "He teaches VC and PE classes at the Stanford Graduate School of Business and leads the Stanford GSB's Venture Capital Initiative." |
| Blake Jackson | Co-creator of the Strebulaev-Jackson Venture Ranking | Co-built the 230,000-investment dataset underlying the ranking | "So together with Blake Jackson I built an alternative: the 2026 Strebulaev-Jackson Venture Ranking." |
| Will Gornall | Academic collaborator (implied University affiliation) | Co-authored research quantifying the ~50% overstatement of unicorn valuations | "My work with Will Gornall put the average overstatement for unicorns near 50%." |
5. Operating Insights
Insight 1: Screen for Partner, Not Logo — Then Reference-Check Their Worst Days
The most actionable fundraising insight in the article is to go one level deeper than firm brand and diligence the individual partner, specifically on how they behave when things go wrong.
"Ask who specifically will work with you, what else they are carrying and how long they have been at the firm. Then reference-check that person with founders they have backed, including the ones whose companies did not work out. How an investor behaves in a down round is the information you most need, and no ranking, ours included, can supply it."
Insight 2: Competitive Round Pressure Is Precisely When You Should Slow Down on Investor Selection
The article makes a structural point about misaligned incentives during hot fundraising moments that founders consistently get wrong.
"An investor is your partner for seven, ten, sometimes fifteen years. That is longer than many marriages and considerably harder to exit. You can sell your house, change your product or replace your team. You cannot easily remove an investor from your cap table or your board. That asymmetry should make you slow down at precisely the moment a competitive round pressures you to speed up."
Insight 3: Match Investor Involvement Model to Your Actual Needs Before Targeting by Rank
Different top-ranked firms operate on fundamentally different models, and choosing the wrong model — even from a highly ranked firm — can be costly.
"A founder who wants an engaged thought partner and a founder who wants capital plus autonomy should be targeting different firms from the same top 100. A high rank cannot tell you which of the two you are dealing with."
6. Overlooked Insights
Overlooked Insight 1: A Decade Is Now Sufficient to Build a World-Class VC Track Record
Conventional LP wisdom holds that VC franchise quality requires multi-decade proof. The data challenges this.
"Twenty-one of the top 100 firms were founded in 2015 or later, and several rocketed up on a single recent, fast-appreciating bet... Track record compounds, and a decade is enough to build one."
This has implications for both founders (younger, hungrier firms may be underrated targets) and LPs (the case for only backing established franchises is weaker than assumed).
Overlooked Insight 2: More Than Half of the Top 100 Individual VCs Don't Appear on the Midas List at All
The upcoming individual-level ranking data, briefly teased at the end, may be the most disruptive finding of the entire research program — yet it's mentioned only in passing.
"More than half of our top 100 individual VCs appear nowhere on the 2026 Forbes Midas List."
If true, this means the list most founders and journalists use to identify star investors excludes the majority of actual top performers — a systematic blind spot with direct fundraising consequences.